AI assistant
PIRAMAL PHARMA LIMITED — Call Transcript 2023
Jul 28, 2023
59525_rns_2023-07-28_6954b1b0-8a37-4fd3-805f-acec1b389cfb.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [145 x 60] intentionally omitted <==
28[th ] July, 2023
BSE Limited P.J. Towers, Dalal Street, Fort, Mumbai- 400 001 BSE scrip code: 543635
National Stock Exchange of India Limited Exchange Plaza, Bandra-Kurla Complex, Bandra (East), Mumbai – 400 051 NSE symbol: PPLPHARMA
Sub: Intimation of Conference Call with Investors/Analysts under the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 (‘Listing Regulations’)
Dear Sir / Madam,
Pursuant to Regulation 30(6) of the Listing Regulations, please find enclosed herewith the details of the Conference Call with investors/ analysts.
Kind take this on record.
Thanking you,
Yours truly,
For Piramal Pharma Limited
TANYA Digitally signed by TANYA SANISH SANISH Date: 2023.07.28 17:51:38 +05'30'
Tanya Sanish Company Secretary
Piramal Pharma Limited CIN: U24297MH2020PLC338592 Registered Office: Gr. Flr. Piramal Ananta, Agastya Corporate Park, Opp Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai – 400070 India T +91 22 3802 3000 / 4000
piramal.com
==> picture [145 x 60] intentionally omitted <==
Q1 FY24 Earnings Conference Call
Piramal Pharma Limited will be hosting a conference call for investors / analysts on 4[th ] August 2023 at 4:00 PM (IST) to discuss its Q1FY24 Results.
The dial-in details for the call are as under:
| al Pharma Limited will be hosting a conference call for investors / analysts on4thAugust 202 | al Pharma Limited will be hosting a conference call for investors / analysts on4thAugust 202 | al Pharma Limited will be hosting a conference call for investors / analysts on4thAugust 202 | al Pharma Limited will be hosting a conference call for investors / analysts on4thAugust 202 | |
|---|---|---|---|---|
| 0 PM (IST) to discuss its Q1FY24 Results.ial-in details for the call are as under: | ||||
| Event | Location & Time | Telephone Number | ||
| Conference call on4thAugust, 2023 | India – 4:00 PM IST | +91 22 6280 1461 / +91 22 7115 8320 (PrimaryNumber) | ||
| 1 800 120 1221(Tll f b) | ||||
| USA – 6:30 AM(Eastern Time – New York) | Toll free number18667462133 | |||
| UK – 11:30 AM(London Time) | Toll free number08081011573 | |||
| Singapore – 6:30 PM(Singapore Time) | Toll free number8001012045 | |||
| Hong Kong – 6:30 PM(HongKongTime) | Toll free number800964448 | |||
| Express Join withDiamond Pass™ | Please use this link for prior registration to reduce wait time at the time of joining thecall –https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=9503078&linkSecurityString=33aa158d84 |
About Piramal Pharma Ltd:
Piramal Pharma Limited (PPL, NSE: PPLPHARMA | BSE: 543635), offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 17 global facilities and a global distribution network in over 100 countries. PPL includes Piramal Pharma Solutions (PPS), an integrated Contract Development and Manufacturing Organization; Piramal Critical Care (PCC), a Complex Hospital Generics business; and the India Consumer Healthcare business, selling over-the-counter products. In addition, PPL has a joint venture with Allergan, a leader in ophthalmology in the Indian formulations market. In October 2020, PPL received 20% strategic growth investment from the Carlyle Group.
For more information visit: https://www.piramal.com/pharma/, Facebook, Twitter, LinkedIn
For Media Queries: For Investors: Rajiv Banerjee Gagan Borana Group Head - Corporate Communications General Manager - Investor Relations & Sustainability [email protected] [email protected]
Piramal Pharma Limited CIN: U24297MH2020PLC338592 Registered Office: Gr. Flr. Piramal Ananta, Agastya Corporate Park, Opp Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai – 400070 India T +91 22 3802 3000 / 4000
piramal.com